Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension

被引:136
作者
Meyer, FJ [1 ]
Lossnitzer, D [1 ]
Kristen, AV [1 ]
Schoene, AM [1 ]
Kübler, W [1 ]
Katus, HA [1 ]
Borst, MM [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Cardiol & Resp Med, D-69120 Heidelberg, Germany
关键词
exercise test; pulmonary hypertension; respiratory function test; respiratory muscles;
D O I
10.1183/09031936.04.00095804
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary arterial hypertension (IPAH) is a pulmonary vasculopathy of unknown aetiology. Dyspnoea, peripheral airway obstruction and inefficient ventilation are common in IPAH. Data on respiratory muscle function are lacking. This prospective single-centre study included 26 female and 11 male patients with IPAH in World Health Organization functional classes II-IV. Mean +/- SD pulmonary artery pressure was 48.6 +/- 16.9 in females and 53.1 +/- 22.9 mmHg in males; cardiac output was 3.7 +/- 1.3 and 4.2 +/- 1.7 L (.) min(-1). Maximal inspiratory pressure (PI,max) was lower in the female patients than in 20 controls (5.3 +/- 2.0 versus 8.2 +/- 2.0 kPa). In the male patients, PI,max was lower than in 25 controls (6.8 +/- 2.2 versus 10.5 +/- 3.7 kPa). Maximal expiratory pressure (PE,max) was lower in the female patients than in controls (6.2 +/- 2.6 versus 9.5 +/- 2.1 kPa), and in male patients as compared to controls (7.1 +/- 1.6 versus 10.3 +/- 3.9 kPa). There was no correlation between PI,max or PE,max and parameters of pulmonary haemodynamics or exercise testing. The ratio of mouth occlusion pressure within the first 0.1 s of inspiration and PI,max was higher in IPAH than in controls (females 0.067 +/- 0.066 versus 0.021 +/- 0.008; males 0.047 +/- 0.061 versus 0.023 +/- 0.016). In conclusion, this study provides the first evidence of inspiratory and expiratory muscle weakness in idiopathic pulmonary arterial hypertension. The pathomechanisms and the prognostic significance should be further investigated.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 41 条
[1]   Electrophysiologic techniques for the assessment of respiratory muscle function [J].
Aldrich, TK ;
Sinderby, C ;
McKenzie, DK ;
Estenne, M ;
Gandevia, SC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) :548-+
[2]   STATISTICAL GUIDELINES FOR CONTRIBUTORS TO MEDICAL JOURNALS [J].
ALTMAN, DG ;
GORE, SM ;
GARDNER, MJ ;
POCOCK, SJ .
BRITISH MEDICAL JOURNAL, 1983, 286 (6376) :1489-1493
[3]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[4]  
BLACK LF, 1969, AM REV RESPIR DIS, V99, P696
[5]   REFERENCE VALUES OF MAXIMAL RESPIRATORY MOUTH PRESSURES - A POPULATION-BASED STUDY [J].
BRUSCHI, C ;
CERVERI, I ;
ZOIA, MC ;
FANFULLA, F ;
FIORENTINI, M ;
CASALI, L ;
GRASSI, M ;
GRASSI, C .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (03) :790-793
[6]  
CHUA TP, 1995, BRIT HEART J, V74, P381
[7]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[8]   CORTICOSTEROIDS CONTRIBUTE TO MUSCLE WEAKNESS IN CHRONIC AIR-FLOW OBSTRUCTION [J].
DECRAMER, M ;
LACQUET, LM ;
FAGARD, R ;
ROGIERS, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :11-16
[9]  
DETROYER A, 1985, THORAX, P1089
[10]   ALTERATIONS OF SKELETAL-MUSCLE IN CHRONIC HEART-FAILURE [J].
DREXLER, H ;
RIEDE, U ;
MUNZEL, T ;
KONIG, H ;
FUNKE, E ;
JUST, H .
CIRCULATION, 1992, 85 (05) :1751-1759